CN101002833A - Traditional Chinese medicine for treating psoriasis - Google Patents
Traditional Chinese medicine for treating psoriasis Download PDFInfo
- Publication number
- CN101002833A CN101002833A CN 200710019578 CN200710019578A CN101002833A CN 101002833 A CN101002833 A CN 101002833A CN 200710019578 CN200710019578 CN 200710019578 CN 200710019578 A CN200710019578 A CN 200710019578A CN 101002833 A CN101002833 A CN 101002833A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- treating psoriasis
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for treating psoriasis is prepared from realgar, natural indigo, red sage root, traimcinolone acetonide hydrochloride, VE, VBb, VC and urea.
Description
Technical field:
The present invention relates to a kind of medicine, is the psoriatic medicine of treatment.
Background technology:
Not clear to the psoriatic cause of disease at present, thereby it is also few on China's pharmaceutical market to treating psoriatic medicament categories, existing medicine is hormone drugs mostly, the quasi drugs of Chinese patent medicine, and Therapeutic Method such as Chinese medicine for oral administration decoction and physical therapy, also have some anti-swollen medicines (because of toxic and side effects big, now few doctor uses), but above these medicines are used on one's body the patient, and the overwhelming majority does not play much effects, therefore, to the treatment of this disease, have only the medical personnel on each medical battle line, each doing his best in performance, the treatment method of the length of each skill, treat the dermatosis that this obstinate difficulty heals, but, generally speaking, do not reach ideal therapeutic effect far away.
Summary of the invention:
The object of the present invention is to provide a kind of psoriatic medicine of the effective treatment of psoriasis for the treatment of.
Technical solution of the present invention is:
The psoriatic medicine of a kind of treatment, it is characterized in that: the component by following weight portion is made:
5～10 parts of 2～5 parts of Indigo Naturaliss of Realgar
0.05～0.1 part of 5～10 parts of triamcinolone acetonide acetate of Radix Salviae Miltiorrhizae
0.05～0.1 part of 0.5～1.0 part of vitamin B6 of vitamin E
5～10 parts in 0.5～1.0 part of carbamide of vitamin C.
It is effective that the present invention treats psoriasis, according to statistics, and through psoriasis people 213 philtrums of the present invention's treatment, first visit patient 98 people are through invalid excessively patient 115 people of hospitalize, wherein through 45 people of 1 hospitalize, through 28 people of 2 hospitalizes, through 41 people of 3～7 hospitalizes.213 philtrums are cured 194 people of (complete) after Drug therapy of the present invention, cure rate reaches 91%, and (criterion of therapeutical effect: complete: skin lesion all disappears total effective rate 100%, and skin recovers normal or leaves temporary pigmented spots; Produce effects: skin lesion disappears more than 70%; Effectively: skin lesion disappears 40～70%; Produce effects with effectively add up to effective percentage.)。This medicine has positive effect equally to treatment seborrheic dermatitis, neurodermatitis, skin itching disease and wet disease, newborn diapers dermatitis etc., can very fast recovery from illness.
The present invention is easy to use, is applied to the affected part 2～3 times on the 1st to get final product, and curative effect is outstanding, and is safe and reliable, economic actual effect.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
The each component of following weight portion fully is mixed and made into product:
2 parts of Realgars (Powdered), 7 parts of Indigo Naturaliss (Powdered), 10 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.05 part of triamcinolone acetonide acetate, 0.5 part of vitamin E, 0.08 part of vitamin B6,1.0 parts of vitamin Cs, 10 parts in carbamide.Be applied to the affected part and get final product for 2～3 times on the 1st.
Embodiment 2:
Each components by weight percent consumption is:
3 parts of Realgars (Powdered), 10 parts of Indigo Naturaliss (Powdered), 7 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.08 part of triamcinolone acetonide acetate, 0.8 part of vitamin E, 0.05 part of vitamin B6,0.5 part of vitamin C, 8 parts in carbamide.All the other are with embodiment 1.
Embodiment 3:
Each components by weight percent consumption is:
5 parts of Realgars (Powdered), 5 parts of Indigo Naturaliss (Powdered), 5 parts of Radix Salviae Miltiorrhizaes (Powdered), 0.1 part of triamcinolone acetonide acetate, 1 part of vitamin E, 0.1 part of vitamin B6,0.8 part of vitamin C, 5 parts in carbamide.All the other are with embodiment 1.
Claims (1)
1, the psoriatic medicine of a kind of treatment, it is characterized in that: the component by following weight portion is made:
5～10 parts of 2～5 parts of Indigo Naturaliss of Realgar
0.05～0.1 part of 5～10 parts of triamcinolone acetonide acetate of Radix Salviae Miltiorrhizae
0.05～0.1 part of 0.5～1.0 part of vitamin B6 of vitamin E
5～10 parts in 0.5～1.0 part of carbamide of vitamin C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100195781A CN100551394C (en) | 2007-01-19 | 2007-01-19 | Treat psoriatic medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100195781A CN100551394C (en) | 2007-01-19 | 2007-01-19 | Treat psoriatic medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101002833A true CN101002833A (en) | 2007-07-25 |
| CN100551394C CN100551394C (en) | 2009-10-21 |
Family
ID=38702359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100195781A Expired - Fee Related CN100551394C (en) | 2007-01-19 | 2007-01-19 | Treat psoriatic medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100551394C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101890042A (en) * | 2009-05-18 | 2010-11-24 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012058826A1 (en) * | 2010-11-05 | 2012-05-10 | Ma Xuerong | Medicine for treating psoriasis |
-
2007
- 2007-01-19 CN CNB2007100195781A patent/CN100551394C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101890042A (en) * | 2009-05-18 | 2010-11-24 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
| CN101890042B (en) * | 2009-05-18 | 2013-06-19 | 上海交通大学医学院附属瑞金医院 | Chinese medicinal compound preparation arsenic tetrasulfide-tanshinone-indirubin and preparation method thereof and application thereof in preparing antineoplastic agents |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100551394C (en) | 2009-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101513522B (en) | Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof | |
| CN103394031B (en) | Medicament for treating sciatica | |
| CN102078462A (en) | Asthma relieving medicament | |
| CN102961614A (en) | Traditional Chinese medicine preparation for treating cerebral thrombosis | |
| CN104288727A (en) | Special healthy traditional Chinese medicine compound preparation for infantile common cold due to wind-cold | |
| CN100551394C (en) | Treat psoriatic medicine | |
| CN102657706A (en) | Infantile anti-cold umbilical therapeutic ointment | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN101721651A (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN103599438B (en) | A kind of Traditional Chinese medicine tincture for the treatment of osteopathia and preparation method thereof | |
| CN103845559A (en) | Traditional Chinese medicine for arthralgia and myalgia | |
| CN102697957A (en) | Traditional Chinese medicine prescription for treating dampness-heat in spleen stomach | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN102228559B (en) | Externally applied ointment for treating children eczema | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101181500B (en) | Externally used medicament for curing respiratory system disease and preparation method thereof | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN101897888A (en) | Traditional Chinese medicine for treating rheumatic heart disease | |
| CN101152361A (en) | Traditional Chinese medicine for treating chronic simple rhinitis | |
| CN104688901A (en) | Traditional Chinese medicine topical agent for preventing constipation of patients with acute myocardial infarction and nursing method | |
| CN105381098A (en) | Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN103263516B (en) | Medicine for treating cholecystitis | |
| CN108114265A (en) | The external traditional Chinese medicine ointment of cure scapulohumeral periarthritis | |
| CN101979046A (en) | Medicament for treating tonsillitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091021 Termination date: 20150119 |
|
| EXPY | Termination of patent right or utility model |